Genomic Life
PrivateLast Round
Early Funding
May 6, 2024
Total Funding Raised
$10M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genomic Life operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was an Early Funding round in May 2024.
Genomic Life is a healthcare and biotechnology company that provides a genetics-based healthcare navigation program offering DNA screenings, personalized health guidance, and cancer navigation services for employees and individuals.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Patient Engagement, Telemedicine
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomic Life Comparables
Compare Genomic Life with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InformedDNA | 79% | |
| Genome Medical | 78% | |
| Color Health, Inc. | 76% |
For institutional investors. Book with your work email.
Genomic Life Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 6, 2024 | ||||
| Series B | Feb 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genomic Life Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Casdin Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 119% MoM.
- May 8, 2025
Bupa now offers Health Insights test in the UK.
For institutional investors. Book with your work email.
Genomic Life Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genomic Life's valuation, stock price, and market status.
Is Genomic Life a public or private company?
Genomic Life is a private company.
What is the current stock price of Genomic Life?
Genomic Life is a private company, so its shares have no public market price. Caplight tracks Genomic Life's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genomic Life worth (valuation)?
Valuation information for Genomic Life is not publicly available.
Can I buy Genomic Life stock?
Genomic Life shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genomic Life's last funding round?
Genomic Life's most recent funding round was Early Funding on May 6, 2024.
Who are the main investors in Genomic Life?
Key investors in Genomic Life include Casdin Capital.
Will Genomic Life IPO soon?
No public IPO plans have been announced for Genomic Life.
How can I track Genomic Life secondary market activity?
Caplight tracks bids, offers, and trades in Genomic Life's shares on secondary markets.